Summary of pharmacokinetic drug-drug interactions for simeprevir (TMC435), a hepatitis C virus Ns3/4A protease inhibitor

Provided by NATAP

14th European AIDS Conference
Oct 16-19 2013
Brussels, Belgium

Reported by Jules Levin
14th European AIDS Conference (EACS)
16-19 October 2013 · Brussels, Belgium

Sivi Ouwerkerk-Mahadevan,1 Alexandru simion,2 Monika Peeters,2 Maria Beumont-Mauviel2
1Janssen Research and Development, Beerse, Belgium; 2Janssen Infectious Diseases, Beerse, Belgium

Address correspondence to:
Sivi Ouwerkerk-Mahadevan,
Janssen Research & Development,
Turnhoutseweg 30, Beerse,
2340 Belgium.
e mail: SOUWERKE@its.jnj.com
Tel: 0032 (0)14605730

Continue here to view posters …..